Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga · 1d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 1d ago
$5M Bet On Pyxis Oncology? Check Out These 4 Penny Stocks Insiders Are Buying
Benzinga · 1d ago
Guggenheim Maintains Neutral Rating for The Oncology Institute: Here's What You Need To Know
Benzinga · 3d ago
--Guggenheim Adjusts Oncology Institute's Price Target to $3 From $6, Keeps Buy Rating
--Guggenheim Adjusts Oncology Institute's Price Target to $3 From $6, Keeps Buy Rating
MT Newswires · 3d ago
CORRECTED-BRIEF-(OFFICIAL)-Oncology Institute Q4 revenue USD 71 million (Mar.9)
Reuters · 6d ago
Reported Late Thursday March 16, The Oncology Institute Reports Updat To Q4 And FY22 Financial Results And Guidance For 2023; Update: $1.5M Increase To The Company's Net Loss For Q4 And A $1.5M Decrease To The Company's Net Income For FY22
Benzinga · 6d ago
-- Earnings Flash (TOI) TOI MANAGEMENT LLC Posts Q4 Revenue $71.4M
-- Earnings Flash (TOI) TOI MANAGEMENT LLC Posts Q4 Revenue $71.4M
MT Newswires · 6d ago
The Oncology Institute reports Q4 results, provides FY 2023 revenue guidance
Seeking Alpha · 03/09 21:24
Earnings Scheduled For March 9, 2023
Benzinga · 03/09 13:00
10 Top Picks For 2023 And Beyond - Part 1: Home Stocks
Seeking Alpha · 02/26 03:46
NMTR and SLRX among healthcare movers
Seeking Alpha · 01/05 15:30
BRIEF-Oncology Institute Rebrands Clinical Trials Division
Reuters · 12/15/2022 13:18
The Oncology Institute Expands into Miami-Dade County, Hires National Oncology Leader Dr. Roberto Ochoa
TOI continues expansion in South FloridaCERRITOS, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, announced its entrance into Miami-Dade Co...
GlobeNewswire · 11/22/2022 13:00
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday
Benzinga · 11/14/2022 07:35
Why Compass Shares Are Trading Higher By Over 56%? Here Are 63 Stocks Moving In Friday's Mid-Day Session
Benzinga · 11/11/2022 17:48
Guggenheim Maintains Buy on The Oncology Institute, Lowers Price Target to $6
Benzinga · 11/11/2022 13:45
--Guggenheim Adjusts Price Target on The Oncology Institute to $6 From $7, Maintains Buy Rating
--Guggenheim Adjusts Price Target on The Oncology Institute to $6 From $7, Maintains Buy Rating
MT Newswires · 11/11/2022 09:51
The Oncology Institute GAAP EPS of -$0.17 misses by $0.01, revenue of $65M misses by $3.95M
Seekingalpha · 11/09/2022 21:46
Webull provides a variety of real-time TOI stock news. You can receive the latest news about The Oncology Institute Inc through multiple platforms. This information may help you make smarter investment decisions.
About TOI
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices that serve patients at approximately 67 clinic locations across 11 markets and four states throughout the United States. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, and dispensary, clinical trial services, radiation, programs like outpatient stem cell transplants and transfusions, along with 24/7 patient support. It offers cutting-edge treatment through clinical trials. It also offers convenient, safe appointments via telehealth. The Company through Innovative Clinical Research Institute, LLC (ICRI), provides and manages clinical trial services and research for the benefit of cancer patients. The Company's segment includes patient care, dispensary, and clinical trials & other. Its managed clinics primarily serve adult and senior cancer patients in markets that have Medicare Advantage (MA) plans.